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morbidity worldwide, but epidemiological data from resource-
constrained tropical settings are scarce. We analysed 293 blood
cultures from patients presenting to a regional referral hospital in
Bouaké, central Côte d’Ivoire, to determine the aetiology of
community-onset BSI. The prevalence of bacteraemia was 22.5%,
with children being most commonly affected. Enterobacteriaceae
(predominantly Klebsiella pneumoniae and Salmonella enterica)
accounted for 94% of BSI. Staphylococcus aureus was the only
relevant Gram-positive pathogen. Clinical signs and symptoms
were not signiﬁcantly associated with blood culture positivity
after controlling for malaria.
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and mortality worldwide [1]. Fever in the tropics is commonly
interpreted as malaria, and empirical treatment is frequently
administered without speciﬁc diagnostic testing [2]. However,
recent research suggests that bacterial and viral infections are
responsible for a large number of febrile illnesses in tropical
settings [3]. For example, studies investigating the causes of
fever in children in Tanzania and Kenya identiﬁed acute respi-
ratory infections in 62% and 41% of symptomatic subjects,
respectively [4,5]. Although viruses account for the majority of
respiratory infections, bacterial BSI are important, yet under-
appreciated pathogens that commonly give rise to life-
threatening systemic infections. Indeed, a recently published
study from a referral hospital in Uganda showed that bacter-
aemia was detected in every ﬁfth febrile child with a negative
malaria test [6]. The diagnosis of invasive bacterial infections in
resource-constrained settings is often limited by inadequate
laboratory infrastructure, and culture-based evaluation of blood
samples is not routinely available [7]. Hence, data on the aeti-
ology of BSI in sub-Saharan Africa are scarce [8].
Access to basic healthcare and the quality of hospital and
laboratory infrastructure might deteriorate during times of
political unrest, armed conﬂict and war [9]. Côte d’Ivoire has
gone through political crisis and armed conﬂict from 1999 to
2011 [10]. Bouaké, the second largest city, with a population of
approximately 700 000 inhabitants, is located in the central part
of the country, some 350 km north of Abidjan, the economic
capital. Bouaké had been at the heart of the military and political
crisis in Côte d’Ivoire. The University Teaching Hospital Bouaké
(UTHB), the country’s only academic hospital outside Abidjan,
had to suspend all except the most basic medical services be-
tween 2002 and 2011. Here, we provide the ﬁrst report on the
aetiology of BSI in Bouaké, facilitated by blood cultures
collected over a 27-month period after the political crisis
ceased.
All venous blood cultures that were processed between June
2012 and September 2014 at UTHB were included for this
study. Blood culture analysis was not feasible before mid-2012 in
Bouaké, and the availability of blood culture reagents was scarceropean Society of Clinical Microbiology and Infectious Diseases
s/by-nc-nd/4.0/)
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taken from severely ill patients, as judged by the attending
physician, within 48 hours of presentation to the hospital, which
led to the classiﬁcation of detected bacteraemia cases as
community-onset BSI [11]. Only a single blood culture was
drawn per patient. Blood samples were taken by a phlebotomist
and sent to the microbiology laboratory, where a conventional
manual blood culture using brain–heart infusion (BHI) broth
(reference no. 64014; Bio-Rad Laboratories; Hercules, CA,
USA) was carried out. The inoculated blood volumes were 10 to
20 mL in 50 mL of BHI broth for adults, 2 to 5 mL in 35 mL of
BHI broth for children and 1 to 2 mL in 35 mL of BHI broth for
newborns. All cultures were aerobically incubated and exam-
ined daily for visible signs of bacterial growth (e.g. turbidity). In
case of suspected growth, a Gram stain was performed and the
sample was cultured on semisolid agar plates. Culture-grown
colonies were identiﬁed using Kligler Iron agar and standard
biochemical tests (e.g. β-galactosidase, indole production, lysine
decarboxylase, oxidase and urease) [12]. All macroscopically
negative blood culture broths were subcultured after 10 days of
incubation to verify the absence of pathogens.
Clinical patient data were collected by chart review after
sample receipt at the laboratory. Data were double-entered
into Microsoft Excel 14.0 (edition 2010; Microsoft, Redmond,
WA, USA), and statistical analysis was performed by Stata 12.0
(StataCorp, College Station, TX, USA). Self-reported clinical
symptoms at admission to the hospital and ﬁndings obtained
during medical examination were assessed for association with
blood culture positivity. Differences in proportions between
bacteraemic and non-bacteraemic individuals were described by
the χ2 test, and the partial correlation test was used to assess
for signiﬁcant correlations between clinical signs and bacter-
aemia while controlling for malaria [13].
Overall, 293 blood cultures were analysed at UTHB from
June 2012 to September 2014. Slightly more than half of theTABLE 1. Aetiology of bloodstream infections in 293 patients presen
d’Ivoire, between June 2012 and September 2014, stratiﬁed by med
Pathogen
Total (n[ 293)
General
paediatrics
(n [ 174)
n % n %
Total positive blood culturesa 66 22.5 48 27.6
Klebsiella pneumoniae 25 8.5 19 10.9
Salmonella enterica 17 5.8 13 7.5
Enterobacter spp. 11 3.8 7 4.0
Escherichia coli 4 1.4 2 1.2
Other Klebsiella spp. 4 1.4 4 2.3
Staphylococcus aureus 4 1.4 3 1.7
Citrobacter spp. 1 0.3 — —
aAdditionally, 11 blood cultures grew coagulase-negative staphylococci and Bacillus spp., which
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This is an open access artiblood cultures were taken from male patients (n = 155, 52.9%).
The median age of the participants was 5 years (mean, 14.3
years; range, 1 day to 83 years). Relevant pathogens were
detected in 66 of the blood samples, owing to a positivity rate
of 22.5%. The prevalence of bacteraemia was 26.5% in male and
17.9% in female patients (p 0.090).
Table 1 summarises the aetiology of the 66 BSI. In brief,
Gram-negative bacteria belonging to the family Enter-
obacteriaceae accounted for 93.9% (62/66) of all BSI. The most
prevalent pathogens were Klebsiella pneumoniae (n = 25, 8.5%),
Salmonella enterica (n = 17, 5.8%) and Enterobacter spp. (n = 11,
3.8%). Staphylococcus aureus, the only relevant Gram-positive
pathogen, was found in four patients (1.4%). Neither fungi
nor non-fermentative Gram-negative bacilli were detected.
Microscopic examination for Plasmodium parasitaemia was
documented in 74 patients, and a positive malaria test result
(based on microscopic examination of Giemsa-stained thick
and thin blood ﬁlms) was signiﬁcantly more common in bac-
teraemic individuals (56.3% vs. 25.9%, p 0.022). BSI was
signiﬁcantly associated with documented febrile convulsions
(24.6% vs. 13.7%; p 0.042) and showed a borderline signiﬁcant
association with self-reported fever (55.7% vs. 42.0%; p 0.057).
However, after using a partial correlation test to control
for malaria, no signiﬁcant correlation between bacterial BSI
and any clinical parameter was observed (Table 2). Fever had
a sensitivity of 56% and a speciﬁcity of 58% for the diagnosis
of BSI.
Anti-infective treatment information was available for 109 of
293 analysed individuals. The third-generation cephalosporin
ceftriaxone was the most commonly administered antibiotic
(53%, n = 58), followed by penicillin derivatives (42%, n = 46;
ampicillin, n = 23; amoxicillin with or without clavulanic acid,
n = 22; penicillin, n = 1). Combination therapy with the ami-
noglycoside gentamicin was administered to 42 patients (39%).
In contrast, other antibiotics were used in less than 5% of theting to the University Teaching Hospital Bouaké, central Côte
ical department
Internal
medicine
(n [ 60)
Neonatology
(n [ 42)
Other
department
(n [ 17)
n % n % n %
7 11.7 8 19.1 3 17.7
1 1.7 3 7.1 2 11.1
3 5.0 — — 1 5.9
2 3.3 2 4.8 — —
— — 2 4.8 — —
— — — — — —
1 1.7 — — — —
— — 1 2.4 — —
were regarded as contaminants, and hence, were not considered for further analysis.
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TABLE 2. Epidemiological, clinical and diagnostic characteristics of 293 bacteraemic and non-bacteraemic patients in Bouaké,
central Côte d’Ivoirea
Characteristic
Data availableb
Bacteraemia
(n [ 66)
No bacteraemia
(n [ 227)
p p after controlling for malariacn n % n %
Sex 278 63 215
Male 155 41 65.1 114 53.0
Female 123 22 34.9 101 47.0 0.090
Age 232 50 182
<1 year 42 8 16.0 34 18.7 0.663
1–5 years 77 24 48.0 53 29.1 0.012
6–15 years 59 10 20.0 49 26.9 0.319
16–25 years 11 0 0 11 6.0 0.075
26–45 years 14 4 8.0 10 5.5 0.510
>45 years 29 4 8.0 25 13.7 0.277
Signs and symptoms 266 61 205
Self-reported fever 120 34 55.7 86 42.0 0.057 0.468
Anaemia 55 15 24.6 40 19.5 0.390 0.139
Convulsions 43 15 24.6 28 13.7 0.042 0.482
Dyspnoea 17 2 3.3 15 7.3 0.375 0.892
Abdominal pain 10 4 6.6 6 2.9 0.244 0.396
Vomiting 8 3 5.0 5 2.4 0.389 0.129
Axillary temperature 190 47 143
38°C 160 37 78.7 123 86.0 0.234 0.388
39°C 121 29 61.7 92 64.3 0.745 0.311
40°C 56 16 34.0 40 28.0 0.428 0.076
41°C 7 3 6.4 4 2.8 0.367 0.201
Microscopy for malaria 74 16 58
Positive 24 9 56.3 15 25.9 0.022
aData were obtained between June 2012 and September 2014.
bMissing data are due to incomplete patient records.
cBased on partial correlation test.
102 New Microbes and New Infections, Volume 7 Number C, September 2015 NMNIpatients (thiamphenicol, n = 2; cotrimoxazole, n = 1; imipenem,
n = 1; metronidazole, n = 1).
In this study, analysis of a single blood culture obtained from
acutely ill patients in central Côte d’Ivoire revealed a high
prevalence (22.5%) of bacterial BSI. Sixty-ﬁve percent of bac-
teraemia cases were detected in male patients, which is in line
with recent research shedding new light on gender differences
in the susceptibility towards bacterial infections [14,15]. Enter-
obacteriaceae accounted for over 90% of all signiﬁcant bacter-
aemia episodes. Such a strong predominance of Gram-negative
pathogens has also been reported from other African settings,
including Burkina Faso [16] and the Democratic Republic of the
Congo [17].
In our patient sample, K. pneumoniae was the most
commonly isolated pathogen, which may be explained by
distinct geographical idiosyncrasy. Indeed, although
K. pneumoniae is an important agent of nosocomial infections
worldwide, recent studies have highlighted its potential to cause
community-onset infections across Africa and Asia [18]. Inva-
sive infections due to typhoidal and particularly non-typhoidal
S. enterica strains are endemic to sub-Saharan Africa [19,20] and
constitute the second most common pathogen in the present
study. Hence, our ﬁndings underscore previous calls for in-
depth investigations to elucidate the epidemiology of
S. enterica in Africa [21], with a particular focus on multidrug-
resistant strains, potential human-to-human transmission andNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licecomplex interactions with highly co-endemic infections such as
HIV and schistosomiasis [22].
In the current setting, children were disproportionately
affected by BSI. Interestingly, no infections with Streptococcus
pneumoniae and only a few S. aureus cases were detected. In
contrast, a recent meta-analysis revealed that S. pneumoniae is
the most common cause of bacteraemia in African children [8],
but this observation does not apply to all African settings [17].
Our study has several limitations. First, the examination of
only a single blood culture per patient as performed here is
relatively insensitive, particularly for the detection of
S. pneumoniae [23] and invasive salmonellosis [24]. Second,
the use of a more sophisticated blood culture detection
system (e.g. automated blood culture incubation and growth
detection) may have further increased the sensitivity of the
microbiological analysis. Third, it was not systematically
assessed whether the patients had received any anti-infective
treatment before they sought care at the hospital. In many
regions of sub-Saharan Africa, antibiotics are readily sold as
over-the-counter drugs and without a medical prescription
[25,26]. Hence, it is likely that many patients in our study had
been self-treated before admission. Many Gram-positive (e.g.
S. aureus and S. pneumoniae) and some Gram-negative path-
ogens (e.g. Haemophilus inﬂuenzae), which commonly cause
community-acquired infections, are sensitive to many
empirically used antibiotics (e.g. penicillin derivatives such asEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 100–104
nses/by-nc-nd/4.0/)
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obacteriaceae are more frequently resistant. Hence, such
pre-treatment may have caused a selection bias in our study
sample that may partially explain the low number of the
aforementioned pathogens.
Fourth, this retrospective observational study had incom-
plete patient chart data, and information on clinical and
epidemiological parameters was thus not fully available to
investigate the association between clinical features and bac-
teraemia. Additionally, the high rates of malaria co-infections in
bacteraemic individuals precluded any distinct attribution of
clinical signs and symptoms to bacterial BSI. Fifth, the number of
obtained blood cultures during the study period was low. Blood
culture diagnostics were re-introduced in the study hospital
after a decade of absent laboratory services, and not all
attending physicians may thus have been aware of this diag-
nostic tool. Moreover, costs for laboratory tests in Côte
d’Ivoire have to be incurred by the patients themselves or their
families, which could have prevented a wider use of blood
culture sampling in febrile but less severely ill patients, thereby
leading to selection bias.
Our study is further limited by the unavailability of sero-
typing methods to differentiate non-typhoidal S. enterica from
typhoidal serovars (Salmonella Typhi and Salmonella Paratyphi)
and by the lack of antimicrobial susceptibility testing for the
detected pathogens. However, these limitations reﬂect the
reality of many hospital settings in sub-Saharan Africa, where
the lack of laboratory infrastructure and accurate diagnostic
testing constitutes a signiﬁcant, yet insufﬁciently addressed
barrier to improved patient management [27]. Indeed, allo-
cation of funds towards an improved availability of reliable
data on antimicrobial resistance patterns in resource-
constrained tropical countries would be highly cost-effective
and could signiﬁcantly affect the mortality and morbidity
rates due to bacterial BSI [28]. The paramount importance of
microbiologic diagnostics is further underscored by our
observation that clinical parameters alone (e.g. fever) were
not sufﬁciently sensitive to predict BSI, thereby conﬁrming
previous ﬁndings from paediatric studies in Guinea-Bissau [29]
and Kenya [30].
In conclusion, we provide the ﬁrst report on the aetiology
of BSI in central Côte d’Ivoire after a decade-long disruption
of diagnostic laboratory activities due to political unrest and
armed conﬂict. We identiﬁed a high prevalence of BSI that
was almost exclusively attributable to Enterobacteriaceae. K.
pneumoniae and S. enterica accounted for >50% of all detected
pathogens. Further research on these bacteria is warranted to
elucidate their epidemiology, virulence characteristics, resis-
tance patterns and clinical presentation in Côte d’Ivoire and
elsewhere in sub-Saharan Africa.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf
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